SCHEMBL19468567

SCHEMBL19468567

COc1ccc(OC)c(/C=C/C(=O)c2ccc(OC)c(OC)c2)c1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 6/20 0.86
▸ KDM4E B2RXH2 1/20 0.76
▸ LMNA P02545 1/20 0.76
▸ MAPT P10636 1/20 0.76
▸ ATM Q13315 1/20 0.76
▸ SMN1; SMN2 Q16637 1/20 0.76
▸ L3MBTL1 Q9Y468 1/20 0.76
▸ TNFRSF1A P19438 3/20 0.72
▸ RELA Q04206 2/20 0.72
▸ POLB P06746 1/20 0.70
▸ JUN P05412 1/20 0.68
▸ NFKB1 P19838 1/20 0.68
▸ PDE4A P27815 1/20 0.68
▸ PDE4B Q07343 1/20 0.68
▸ PDE4C Q08493 1/20 0.68
▸ PDE4D Q08499 1/20 0.68
▸ CDC25A P30304 1/20 0.65
▸ CDC25C P30307 1/20 0.65
▸ TDP1 Q9NUW8 1/20 0.64
▸ ABCB1 P08183 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185011 0.91 ABCG2 (0.97) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7185006 0.91 ABCG2 (0.97) ABCG2KDM4ELMNAMAPTATM
SCHEMBL28261935 0.90 TNFRSF1A (0.82) ABCG2KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL28263078 0.88 ABCG2 (0.80) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7188211 0.87 ABCG2 (0.79) ABCG2KDM4ELMNAMAPTATM
SCHEMBL7188219 0.87 ABCG2 (0.79) ABCG2KDM4ELMNAMAPTATM
SCHEMBL5424613 0.87 ABCG2 (0.79) ABCG2KDM4ELMNAMAPTATM
SCHEMBL6352780 0.87 ABCG2 (0.89) ABCG2KDM4ELMNAMAPTATM
SCHEMBL30307319 0.87 ABCG2 (0.89) ABCG2KDM4ELMNAMAPTATM
SCHEMBL5424620 0.87 ABCG2 (0.79) ABCG2KDM4ELMNAMAPTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108904481-A O-hydroxylate chalcone analog is preparing the application in anti-oxidation medicine 温州医科大学 2018-11-30 — — CN disclosed
EP-3278797-A1 ANTIALLERGIC AGENT Tohoku University (JP) 2018-02-07 — — EP disclosed
US-20170304236-A1 ANTIALLERGIC AGENT TOHOKU UNIVERSITY (JP) 2017-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170304236-A1 ANTIALLERGIC AGENT HRH2, HRH4, HRH1 ABCG2 2921/4885KDM4E 2907/4885LMNA 4698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback